Aravive Inc logo

Aravive Inc Share Price (NASDAQ: ARAV)

▲

-0.04

(-100%)

Last updated on

Bell Icon

This instrument is not available for trading on the INDmoney app on 26 Jan 2024

Check the interactive Aravive Inc Stock chart to analyse performance

Aravive Inc Key Stats

Check Aravive Inc key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$0.0401
Open
$0.0435
Market Capitalization
$2.9M
Today's Volume
$3.9M
Revenue TTM
$7.0M
EBITDA
$-58.4M
Earnings Per Share (EPS)
$-0.76
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-475.98%

Global Institutional Holdings in Aravive Inc

  • Name

    Holdings %

  • XTX Topco Ltd

    0.15%

  • MASSMUTUAL TRUST CO FSB/ADV

    0.01%

Analyst Recommendation on Aravive Inc Stock

Rating
Trend

Sell

    0%Buy

    50%Hold

    50%Sell

Based on 6 Wall street analysts offering stock ratings for Aravive Inc(by analysts ranked 0 to 5 stars)

About Aravive Inc

Aravive, Inc., a clinical-stage biopharmaceutical company, develops transformative treatments for life-threatening diseases, including cancer and fibrosis in the United States. Its lead product candidate is batiraxcept, an ultrahigh-affinity, decoy protein that targets the GAS6-AXL signaling pathway, which is in Phase III clinical trial for the treatment of platinum- resistant recurrent ovarian cancer; and in Phase Ib/II clinical trial for the treatment of clear cell renal cell carcinoma and pancreatic adenocarcinoma. The company also develops AVB-S6, a soluble Fc-fusion protein to block the activation of the GAS6-AXL signaling pathway. It has a license and collaboration agreement with WuXi Biologics (Hong Kong) Limited to identify and develop novel high-affinity bispecific antibodies targeting cancer and fibrosis; and license agreement with 3D Medicines Inc. to develop products that contain batiraxcept as the sole drug substance for the treatment of human oncological diseases in mainland China, Taiwan, Hong Kong, and Macau. The company was formerly known as Versartis, Inc. and changed its name to Aravive, Inc. in October 2018. Aravive, Inc. was incorporated in 2008 and is headquartered in Houston, Texas.
Organization
Aravive Inc
Employees
23
CEO
Dr. Fredric N. Eshelman Pharm.D.
Industry
Health Technology

Important FAQs about investing in ARAV Stock from India :

What is Aravive Inc share price today?

Aravive Inc share price today is as on at the close of the market. Aravive Inc share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.

What is the 52 week high and 52 week low for Aravive Inc share?

Aravive Inc share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Aravive Inc stock price today i.e. is closed at , lower by 100% versus the 52 week high.

How to invest in Aravive Inc Stock (ARAV) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Aravive Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Aravive Inc Shares .

What is the minimum amount required to buy Aravive Inc Stock (ARAV) from India?

Indian investors can start investing in Aravive Inc (ARAV) shares with as little as ₹92.513 or $1 (as of April 11, 2026) using the INDmoney app.
For example: If you want to invest $10 or ₹925.13 in Aravive Inc stock (as per the Rupee-Dollar exchange rate as on April 11, 2026). Learn more about fractional shares .

What are the returns that Aravive Inc has given to Indian investors in the last 5 years?

Aravive Inc stock has given 0.0% share price returns and 23.37% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?